We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On 5 July 2010, the European Commission (the "Commission") published its first report on its monitoring of patent settlements in the pharmaceutical sector (the "Report"
On 1 July 2010, the General Court of the European Union (the "General Court") handed down its eagerly awaited judgment in relation to AstraZeneca's appeal against a 2005 decision of the European Commission (the "Commission") finding that AstraZeneca had abused its dominant position by blocking or delaying generic versions of its drug Losec
